Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With <i>MYC</i> and <i>BCL6</i> Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Liu, Hui; Shen, Qi; Chang, Chung-Che; Hu, Shimin

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Liu, Hui; Shen, Qi; Chang, Chung-Che; Hu, Shimin.

Afiliación

Liu H; Department of Pathology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Shen Q; Department of Pathology & Laboratory Medicine, AdventHealth Cancer Institute, Orlando, FL, United States.
Chang CC; Department of Pathology & Laboratory Medicine, AdventHealth Cancer Institute, Orlando, FL, United States.
Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Front Oncol ; 11: 795330, 2021.

Article en En | MEDLINE | ID: mdl-35004320

Palabras clave

BCL2; BCL6; High-grade B-cell lymphoma; MYC; lineage switch; plasmablastic lymphoma; plasticity; therapeutic resistance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google